<SEC-DOCUMENT>0001737287-20-000010.txt : 20200227
<SEC-HEADER>0001737287-20-000010.hdr.sgml : 20200227
<ACCEPTANCE-DATETIME>20200227073033
ACCESSION NUMBER:		0001737287-20-000010
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200227
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200227
DATE AS OF CHANGE:		20200227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allogene Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001737287
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				823562771
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38693
		FILM NUMBER:		20658479

	BUSINESS ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 457-2700

	MAIL ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>allo-20200227.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:63d55a2a-a427-4376-ad15-f937a6d11062,g:e3ecc39a-1fdd-4f9b-b1f4-7a8fb27e5f03,d:8e2a5abb73914885a3fa83aafb64166e--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>allo-20200227</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xMzQvZnJhZzpmMjg5M2E2MzM5ZjY0ZmU5ODY2ZjJhOTgwNmE1NDM0MC90YWJsZToyOWI2NWYxYjQ2ZTg0MGU4YWQ1YWNjY2U1Y2I0OGRkZi90YWJsZXJhbmdlOjI5YjY1ZjFiNDZlODQwZThhZDVhY2NjZTVjYjQ4ZGRmXzEtMS0xLTEtNTk_fe55962b-5737-47b0-8602-acdeba8dfb8e">0001737287</ix:nonNumeric><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xMzQvZnJhZzpmMjg5M2E2MzM5ZjY0ZmU5ODY2ZjJhOTgwNmE1NDM0MC90YWJsZToyOWI2NWYxYjQ2ZTg0MGU4YWQ1YWNjY2U1Y2I0OGRkZi90YWJsZXJhbmdlOjI5YjY1ZjFiNDZlODQwZThhZDVhY2NjZTVjYjQ4ZGRmXzItMS0xLTEtNTk_d1aea073-bde0-4713-8d56-e75583408647">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="allo-20200227.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001737287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-27</xbrli:startDate><xbrli:endDate>2020-02-27</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8e2a5abb73914885a3fa83aafb64166e_1"></div><div style="height:33.75pt;width:100%;"><div><span><br/></span></div></div><div style="margin-top:4pt;"><span><br/></span></div><div style="margin-top:4pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;margin-top:4pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">UNITED STATES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Washington, D.C. 20549</span></div><div style="text-align:center;margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">____________________</span></div><div style="text-align:center;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;">FORM <ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0NzUx_7a8c1e19-4fc2-43e6-aebd-5ead9c7ed79a">8-K</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">____________________</span></div><div style="text-align:center;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">CURRENT REPORT</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Pursuant to Section&#160;13 or 15(d)</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">of the Securities Exchange Act of 1934</span></div><div style="text-align:center;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0Nzgz_32a602e6-a9cb-49c1-9c98-b2517cb22084">February 27, 2020</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">_______________________</span></div><div style="text-align:center;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0Nzk2_b4d17834-6ac9-4da9-b85a-a9420edb393d">Allogene Therapeutics, Inc.</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">____________________________</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:31.235%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:31.382%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:31.383%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6MzM4YTVjMmYyNTJkNDE3OGI0NzAxNWMyZWE3ZjUxZTgvdGFibGVyYW5nZTozMzhhNWMyZjI1MmQ0MTc4YjQ3MDE1YzJlYTdmNTFlOF8wLTAtMS0xLTMy_c779a003-ff60-43c7-b037-01b77ec2a05f">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6MzM4YTVjMmYyNTJkNDE3OGI0NzAxNWMyZWE3ZjUxZTgvdGFibGVyYW5nZTozMzhhNWMyZjI1MmQ0MTc4YjQ3MDE1YzJlYTdmNTFlOF8wLTEtMS0xLTM0_6e96a0d3-c270-47ee-a951-29636bf1eb6a">001-38693</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6MzM4YTVjMmYyNTJkNDE3OGI0NzAxNWMyZWE3ZjUxZTgvdGFibGVyYW5nZTozMzhhNWMyZjI1MmQ0MTc4YjQ3MDE1YzJlYTdmNTFlOF8wLTItMS0xLTM2_87454dbf-53d5-41dc-ae46-7ee2fed15e0d">82-3562771</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">(State or other jurisdiction</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">of incorporation)</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">(Commission</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">File Number)</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">(I.R.S. Employer</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Identification No.)</span></div></td></tr><tr><td colspan="9" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0OTgw_504b1baf-c7a8-4625-859d-00bee4639122">210 East Grand Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg1MDAz_bf3d226e-f225-4af2-80c3-5cf9cfdb9dc5">South San Francisco</ix:nonNumeric>, <ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg1MDI0_73fd3646-16af-4367-8d7b-cacd377bd038">California</ix:nonNumeric> <ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg1MDM2_9ffb7a56-e4b6-4677-8407-caa95f919dae">94080</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">(Address of principal executive offices including zip code)</span></div><div style="text-align:center;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0ODI3_cd1a1c8e-acb1-4ba6-815d-95e8b8ad32e0">650</ix:nonNumeric>) <ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0ODMy_fd78e6ad-64b9-4b20-bcb0-eeeb09ffc557">457-2700</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;">(Former name or former address, if changed since last report.)</span></div><div style="text-align:center;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;">________________________________</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:2.838%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.732%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:90.230%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6OWQ0NTAxYTY2NjFjNDZlODlhZDI5ZGJlNjdhNDY0MDgvdGFibGVyYW5nZTo5ZDQ1MDFhNjY2MWM0NmU4OWFkMjlkYmU2N2E0NjQwOF8wLTEtMS0xLTcx_b025f698-e50b-4d36-8bf2-a84c1731cf3e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6OWQ0NTAxYTY2NjFjNDZlODlhZDI5ZGJlNjdhNDY0MDgvdGFibGVyYW5nZTo5ZDQ1MDFhNjY2MWM0NmU4OWFkMjlkYmU2N2E0NjQwOF8xLTEtMS0xLTcx_2adb02d5-2a87-45a7-9a85-178e8da172a3">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6OWQ0NTAxYTY2NjFjNDZlODlhZDI5ZGJlNjdhNDY0MDgvdGFibGVyYW5nZTo5ZDQ1MDFhNjY2MWM0NmU4OWFkMjlkYmU2N2E0NjQwOF8yLTEtMS0xLTcx_c564a973-be5a-4fc0-8ce8-7ff340f14c5e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6OWQ0NTAxYTY2NjFjNDZlODlhZDI5ZGJlNjdhNDY0MDgvdGFibGVyYW5nZTo5ZDQ1MDFhNjY2MWM0NmU4OWFkMjlkYmU2N2E0NjQwOF8zLTEtMS0xLTcx_091b3656-2e35-4110-a0c7-854777956acd">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:30.844%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:30.844%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:30.846%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of each class</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Trading</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Symbol(s)</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Name&#160;of&#160;each&#160;exchange</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">on&#160;which&#160;registered</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6YjY5MjdmN2QzOGUxNDUzYWE2OThhNWU4MjY0MDY5YzMvdGFibGVyYW5nZTpiNjkyN2Y3ZDM4ZTE0NTNhYTY5OGE1ZTgyNjQwNjljM18xLTAtMS0xLTE2OA_f480cb6f-0316-4deb-b739-53ac32f2e12a">Common&#160;Stock,&#160;$0.001&#160;par&#160;value&#160;per&#160;share</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6YjY5MjdmN2QzOGUxNDUzYWE2OThhNWU4MjY0MDY5YzMvdGFibGVyYW5nZTpiNjkyN2Y3ZDM4ZTE0NTNhYTY5OGE1ZTgyNjQwNjljM18xLTItMS0xLTE2OA_ed00b22d-03f0-4de1-bf63-4246859a7456">ALLO</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6YjY5MjdmN2QzOGUxNDUzYWE2OThhNWU4MjY0MDY5YzMvdGFibGVyYW5nZTpiNjkyN2Y3ZDM4ZTE0NTNhYTY5OGE1ZTgyNjQwNjljM18xLTQtMS0xLTE3MA_60d2bb4c-8192-4bfb-9885-0fca7b04605f">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule 12b&#8211;2 of the Securities Exchange Act of 1934 (&#167;&#160;240.12b&#8211;2 of this chapter).</span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Emerging growth company  <ix:nonNumeric contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg1MDQ5_7a5483ac-200d-464b-a732-0034602276de">&#9744;</ix:nonNumeric></span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</span></div><div style="margin-top:9pt;"><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div id="i8e2a5abb73914885a3fa83aafb64166e_4"></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="height:42.75pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item&#160;2.02&#160;Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On February 27, 2020, Allogene Therapeutics, Inc. (the &#8220;Company&#8221;) provided a corporate update and announced its financial results for the fourth quarter and year ended December 31, 2019 in the press release attached hereto as Exhibit&#160;99.1 and incorporated herein by reference.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The information in this Item&#160;2.02, including the attached Exhibit 99.1, is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></div><div id="i8e2a5abb73914885a3fa83aafb64166e_7"></div><div style="margin-top:10pt;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item&#160;9.01&#160;Financial Statements and Exhibits.</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:12.076%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:83.191%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(d) Exhibits</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Exhibit</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Number</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="allo-20200227xexx991q4.htm">Press Release of the Company, dated February 27, 2020.</a></span></div></td></tr></table></div><div><span><br/></span></div><div id="i8e2a5abb73914885a3fa83aafb64166e_10"></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">SIGNATURES</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:56.125%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.099%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:27.721%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.055%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ALLOGENE THERAPEUTICS, INC.</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="6" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">By:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ David Chang, M.D., Ph.D.</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">David Chang, M.D., Ph.D.</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">President, Chief Executive Officer</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Dated: February 27, 2020</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>allo-20200227xexx991q4.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="iaa7ce8e806c04b4bb4a061f2d32678b4_1"></div><div style="height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;margin-bottom:10pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Exhibit 99.1</font></div><div style="margin-top:10pt;"><img alt="g725933allogenea061.jpg" src="g725933allogenea061.jpg" style="height:41px;width:176px;"></div><div style="padding-right:9pt;text-align:center;"><font><br></font></div><div style="padding-right:9pt;text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;">Allogene Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results </font></div><div style="padding-right:9pt;text-align:center;"><font><br></font></div><div style="text-indent:-18pt;padding-left:45pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Initial Results from the Phase 1 ALLO-501 ALPHA Trial in Relapsed&#47;Refractory Non-Hodgkin Lymphoma and Phase 1 ALLO-715 UNIVERSAL Trial in Relapsed&#47;Refractory Multiple Myeloma On-Track for Q2 2020 and Q4 2020, Respectively </font></div><div style="text-indent:-18pt;padding-left:45pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">ALLO-501A, the Next Generation anti-CD19 AlloCAR T Intended for Phase 2 Development, Received IND Clearance from the U.S. FDA. Company Expects to Initiate an Abbreviated Phase 1 Trial in Q2 2020</font></div><div style="text-indent:-18pt;padding-left:45pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Combination Trial of ALLO-715 and SpringWorks Therapeutics&#8217; Gamma Secretase Inhibitor, Nirogacestat, Expected to Commence in the Second Half of 2020</font></div><div style="text-indent:-18pt;padding-left:45pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">IND Submission for Next Clinical Candidate, ALLO-316, an anti-CD70 AlloCAR T</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">TM</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">,</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"> </sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Targeted for Year End 2020 </font></div><div style="text-indent:-18pt;padding-left:45pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Ended 2019 with $589 Million in Cash, Cash Equivalents and Investments</font></div><div style="text-indent:-18pt;padding-left:45pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Conference Call and Webcast Scheduled for 5&#58;30 AM PT&#47;8&#58;30 AM ET</font></div><div style="padding-right:9pt;text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">SOUTH SAN FRANCISCO, Calif., February 27, 2020 &#8211; Allogene Therapeutics, Inc. (Nasdaq&#58; ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T&#8482;) therapies for cancer, today provided a corporate update and reported fourth quarter and full-year 2019 financial results for the periods ended December 31, 2019. </font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#34;2019 was a very successful year for Allogene. We accomplished all of our corporate goals, which includes the establishment of world-class capabilities across multiple new functions and the initiation of our first clinical trials in patients with relapsed or refractory aggressive non-Hodgkin lymphoma and multiple myeloma,&#34; said David Chang, M.D., Ph.D., President, Chief Executive Officer and Co-Founder of Allogene. &#34;Our momentum and focus towards making AlloCAR T therapies and their life-saving potential a reality for patients will continue at full speed in 2020. This year will be an important one as we look to demonstrate proof-of-concept data from two key programs and plan for potential pivotal studies.&#34;</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Recent Highlights</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">ALLO-501 (anti-CD19 AlloCAR T)</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">In 2019, Allogene initiated the ALLO-501 Phase 1 ALPHA trial in patients with relapsed&#47;refractory non-Hodgkin lymphoma (NHL). This study utilizes ALLO-647, Allogene's anti-CD52 monoclonal antibody (mAb) as a part of the lymphodepletion regimen. Initial data is planned to be presented at a medical meeting in Q2 2020.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">The U.S. Food and Drug Administration cleared the Investigational New Drug Application (IND) for ALLO-501A, the Company&#8217;s next generation anti-CD19 AlloCAR T construct devoid of the rituximab off-switch. ALLO-501A, previously referred to as ALLO-501.1, was created to eliminate the rituximab recognition domains in ALLO-501, allowing for use in a broader patient population, including those NHL patients with recent rituximab exposure. </font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">The Company expects to initiate an abbreviated Phase 1 portion of the ALLO-501A trial (ALPHA2) in the second quarter of the year. The ALPHA2 trial will leverage the findings of the ALPHA trial to finalize the ALLO-501A cell dose and the ALLO-647 based lymphodepletion regimen for a potential pivotal Phase 2 trial. </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">ALLO-715 (anti-BCMA AlloCAR T)</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">The Company has created a robust anti-BCMA strategy centered around ALLO-715 for the treatment of multiple myeloma (MM).</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">In 2019, Allogene initiated the ALLO-715 Phase 1 UNIVERSAL trial in patients with relapsed&#47;refractory MM, designed to assess the safety and tolerability of ALLO-715.  This trial is also intended to identify the optimal dose of ALLO-647 and includes the potential to evaluate lymphodepletion regimens that do not include fludarabine and cyclophosphamide. UNIVERSAL continues to accrue as planned with initial data anticipated in Q4 2020.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">In January 2020, Allogene entered into a clinical collaboration with SpringWorks Therapeutics to evaluate ALLO-715 in combination with SpringWorks&#8217; investigational gamma secretase inhibitor, nirogacestat, in patients with relapsed&#47;refractory MM. The Company expects to initiate this combination trial in the second half of 2020.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">The Company nominated ALLO-605 as its first TurboCAR</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">TM</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> candidate and part of its larger MM strategy. The TurboCAR technology provides the effects of cytokine stimulation to AlloCAR T cells with the goal of enhancing </font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">their potency, expansion and persistence. ALLO-605 is advancing in preclinical development with a potential IND in 2021.</font></div><div><font><br></font></div><div style="text-indent:5pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Additional Pipeline Updates</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">The Company nominated ALLO-316, an anti-CD70 AlloCAR T, as its next clinical candidate for potential development in acute myeloid leukemia, T-cell malignancies and&#47;or renal cell carcinoma. Submission of the IND for ALLO-316 is expected by year end 2020.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Fourth Quarter Financial Results</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">As of December 31, 2019, Allogene had $588.9 million in cash, cash equivalents, and investments. </font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Research and development expenses were $49.4 million for the fourth quarter of 2019, which includes $6.4 million of non-cash stock-based compensation expense and $10.0 million in expenses associated with the signing of our collaboration with Notch Therapeutics. For the full year of 2019, research and development expenses were $144.5 million. Research and development expense for the year includes $19.4 million of non-cash stock-based compensation expense.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">General and administrative expenses were $15.2 million for the fourth quarter of 2019, which includes $7.5 million of non-cash stock-based compensation expense. For the full year of 2019, general and administrative expenses were $57.5 million, which includes $26.6 million of non-cash stock-based compensation expense.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Net loss for the fourth quarter of 2019 was $61.0 million, or $0.58 per share, including non-cash stock-based compensation expense of $13.9 million. For the full year of 2019, our net loss was $184.6 million, or $1.83 per share, including non-cash stock-based compensation expense of $46.1 million.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">2020 Financial Guidance</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Allogene expects full year GAAP net losses to be between $260 million and $280 million including estimated non-cash stock-based compensation expense of $70 million to $75 million and excluding any impact from potential business development activities. </font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Conference Call and Webcast Details</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Allogene will host a live conference call and webcast today at 5&#58;30 a.m. Pacific Time &#47; 8&#58;30 a.m. Eastern Time to discuss financial results and provide a business update. To access the live conference all by telephone, please dial 1 (866) 940-5062 (U.S.) or 1 (409) 216-0618 (International). The conference ID number for the live call is </font><font style="background-color:rgb(255,255,255, 0.0);color:#262626;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">2981059</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. The webcast will be made available on the Company's website at </font><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">www.allogene.com</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> under the Investors tab in the News and Events section. Following the live audio webcast, a replay will be available on the Company's website for approximately 30 days. </font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">About Allogene Therapeutics</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T&#8482;) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, Allogene is developing a pipeline of &#8220;off-the-shelf&#8221; CAR T cell therapy candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients. For more information, please visit www.allogene.com, and follow &#64;AllogeneTx on Twitter and LinkedIn.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cautionary Note on Forward-Looking Statements </font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">This press release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The press release may, in some cases, use terms such as &#34;predicts,&#34; &#34;believes,&#34; &#34;potential,&#34; &#34;proposed,&#34; &#34;continue,&#34; &#34;estimates,&#34; &#34;anticipates,&#34; &#34;expects,&#34; &#34;plans,&#34; &#34;intends,&#34; &#34;may,&#34; &#34;could,&#34; &#34;might,&#34; &#34;will,&#34; &#34;should&#34; or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Forward-looking statements include statements regarding intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things&#58; the timing and ability to progress the clinical trials of ALLO-501 and ALLO-715 and present any proof-of-concept data from the trials, the timing and ability to initiate and progress a clinical trial of ALLO-501A, our collaborator&#8217;s ability to obtain any necessary rights to ALLO-501A, the timing and ability to initiate a clinical trial of ALLO-715 in combination with SpringWorks&#8217; nirogacestat, the timing and ability to file an IND and initiate clinical trials of ALLO-316 and ALLO-605, the ability to manufacture AlloCAR T&#8482; therapies, including ALLO-501A, ALLO-316 and ALLO-605 for use in clinical trials, the potential benefits of AlloCAR T&#8482; therapy and the 2020 financial guidance. Various factors may cause differences between Allogene&#8217;s expectations and actual results as discussed in greater detail in Allogene&#8217;s filings with the Securities and Exchange Commission (SEC), including without limitation in its Form 10-Q for the quarter ended September 30, 2019.  Any forward-looking statements that are made in this press release speak only as of the date of this press release. Allogene assumes no obligation to update the forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.</font></div><div id="iaa7ce8e806c04b4bb4a061f2d32678b4_4"></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:42.75pt;width:100%;"><div><font><br></font></div></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ALLOGENE THERAPEUTICS, INC.</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">SELECTED FINANCIAL DATA</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(unaudited&#59; in thousands, except share and per share data)</font></div><div id="iaa7ce8e806c04b4bb4a061f2d32678b4_7"></div><div style="text-align:center;margin-top:10pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">STATEMENTS OF OPERATIONS</font></div><div style="text-align:center;margin-top:10pt;"><font><br></font></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:49.023%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.695%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.530%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.695%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.530%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.695%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.530%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.702%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended December 31,</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended<br>December 31,</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49,363&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,503&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">144,535&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">151,860&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">General and administrative</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,212&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,543&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57,473&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,982&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating expenses</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64,575&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,046&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">202,008&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">192,842&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss from operations</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(64,575)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33,046)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(202,008)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(192,842)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income (expense), net&#58;</font></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></font></font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></font></font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></font></font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in fair value of convertible note payable</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,796)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19,415)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3,358)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest and other income, net</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,658&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,216&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,351&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,573&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other expenses</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(268)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></font></font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></font></font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(268)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></font></font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss before income taxes</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(61,185)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30,626)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(184,925)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(211,622)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit from income taxes</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">155&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">331&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(61,030)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30,509)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(184,594)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(211,505)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share, basic and diluted</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.58)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.37)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.83)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.31)</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-average number of shares used in computing net loss per share, basic and diluted</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104,800,502&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82,064,497&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101,061,149&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,948,386&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr></table></div><div><font><br></font></div><div id="iaa7ce8e806c04b4bb4a061f2d32678b4_10"></div><div style="text-align:center;margin-top:10pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">SELECTED BALANCE SHEET DATA</font></div><div style="text-align:center;margin-top:10pt;"><font><br></font></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:58.263%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:17.501%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.503%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2019</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31, 2018</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash, cash equivalents and investments</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">588,855&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">721,350&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">717,802&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">773,855&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88,779&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70,691&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total stockholders&#8217; equity</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">629,023&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">703,164&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Allogene Media&#47;Investor Contact&#58;</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Christine Cassiano</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Chief Communications Officer</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(714) 552-0326</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Christine.Cassiano&#64;allogene.com</font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>allo-20200227.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:63d55a2a-a427-4376-ad15-f937a6d11062,g:e3ecc39a-1fdd-4f9b-b1f4-7a8fb27e5f03-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:allo="http://allogene.com/20200227" xmlns:link="http://www.xbrl.org/2003/linkbase" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://allogene.com/20200227">
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="allo-20200227_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="allo-20200227_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="allo-20200227_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="allo-20200227_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://allogene.com/role/DocumentandEntityInformationDocument">
        <link:definition>0001001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>allo-20200227_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:63d55a2a-a427-4376-ad15-f937a6d11062,g:e3ecc39a-1fdd-4f9b-b1f4-7a8fb27e5f03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://allogene.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="allo-20200227.xsd#DocumentandEntityInformationDocument"/>
  <link:calculationLink xlink:role="http://allogene.com/role/DocumentandEntityInformationDocument" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>allo-20200227_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:63d55a2a-a427-4376-ad15-f937a6d11062,g:e3ecc39a-1fdd-4f9b-b1f4-7a8fb27e5f03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://allogene.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="allo-20200227.xsd#DocumentandEntityInformationDocument"/>
  <link:definitionLink xlink:role="http://allogene.com/role/DocumentandEntityInformationDocument" xlink:type="extended" id="i7a5750d27e494f7ebc4a1c3d74765021_6556de6e-8fb3-4b30-b0d3-e25c02c2d0a5"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>allo-20200227_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:63d55a2a-a427-4376-ad15-f937a6d11062,g:e3ecc39a-1fdd-4f9b-b1f4-7a8fb27e5f03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_a2294df4-6318-4612-91f9-45fc4f85a133_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_b358fc88-f605-4fc2-8aa1-74ff6cd90905_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_71dce9bc-5a70-45dd-8727-60a19265c6c1_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1f51139e-216e-4259-8037-e9952496550a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_280c9368-4ed7-41f6-bc08-cd1d6bc7b1d2_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_700d4389-d988-48b1-b5ba-283796d4ab0d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_fedf7157-e717-48bb-aef1-7db16a530cf2_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a635a8f0-fe9c-4449-be1f-ba86576ac22c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_1adfd36d-2353-4766-999c-e478e353371c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_50dd4ef1-8373-4b2b-bbcd-06ebaac2eb52_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7210b544-2e3c-4194-8d4a-c2921a1e1650_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b8948dda-54cb-4077-b979-cc3e131ef156_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_53c408ef-9479-4bac-95f3-48b37d3f0a1e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7ad76548-31a5-4fbe-8bd5-b8d348d244bb_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_45819e55-5e15-491d-ba15-8784a8933730_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_aad631d0-ae8c-428f-80fe-82ff1d3632a0_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_409b205d-e364-4a7b-a972-c53f65c3dbd5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2d1c7fe2-f931-4ae8-bf3b-7898d31e8b58_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9e78f6ea-67e5-45e9-a903-f7e8096cd938_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6e67c93d-2809-483d-8da0-d7801f2715bc_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_afd70aee-7277-41d1-954b-ea02cf3eabc1_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_7aa42781-a4f8-4d04-9ba3-e59cf487d318_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f43f6a3e-2f17-4576-9b79-a88a5c6546ad_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>allo-20200227_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:63d55a2a-a427-4376-ad15-f937a6d11062,g:e3ecc39a-1fdd-4f9b-b1f4-7a8fb27e5f03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://allogene.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="allo-20200227.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://allogene.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c51938a7-c4cf-499b-b532-dfe320e7f259" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_DocumentType_c51938a7-c4cf-499b-b532-dfe320e7f259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c6aca7d6-971b-4920-a705-6e486a88bb53" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_DocumentPeriodEndDate_c6aca7d6-971b-4920-a705-6e486a88bb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c6fff52a-954d-4434-a14b-c4e77bcfeaa5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_EntityRegistrantName_c6fff52a-954d-4434-a14b-c4e77bcfeaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7db84266-434d-4823-b9a3-a918b252eac1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_EntityCentralIndexKey_7db84266-434d-4823-b9a3-a918b252eac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_488681bb-4e3d-499c-b5d3-25639009acf4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_AmendmentFlag_488681bb-4e3d-499c-b5d3-25639009acf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0d15f2ae-8fa3-483e-99fb-b906ec7f7522" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0d15f2ae-8fa3-483e-99fb-b906ec7f7522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_93fca12b-3960-4ac1-83bf-87030359c2de" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_EntityFileNumber_93fca12b-3960-4ac1-83bf-87030359c2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_577eb3c3-172d-43a3-b991-e069ae2c5dc2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_EntityTaxIdentificationNumber_577eb3c3-172d-43a3-b991-e069ae2c5dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_101991c0-ba53-496f-8304-d011d809dff0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_EntityAddressAddressLine1_101991c0-ba53-496f-8304-d011d809dff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7c31df4a-2615-45b2-b226-b332a8671a62" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_EntityAddressCityOrTown_7c31df4a-2615-45b2-b226-b332a8671a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_86abdf17-bd1c-4259-9622-1f80880b9c65" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_EntityAddressStateOrProvince_86abdf17-bd1c-4259-9622-1f80880b9c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_bf24eb0d-b5c4-421c-a551-32193ee6c5fd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_EntityAddressPostalZipCode_bf24eb0d-b5c4-421c-a551-32193ee6c5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3d223c4b-ecb5-4803-881d-618b7d630726" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_CityAreaCode_3d223c4b-ecb5-4803-881d-618b7d630726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_174fa2ea-7cdf-4371-a2f1-f77c21f0bd55" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_LocalPhoneNumber_174fa2ea-7cdf-4371-a2f1-f77c21f0bd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_0365d1b1-6a60-454d-983d-d54fbeb6dead" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_WrittenCommunications_0365d1b1-6a60-454d-983d-d54fbeb6dead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_ebb42f9c-406e-4de8-8695-ea11b982cb1f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_SolicitingMaterial_ebb42f9c-406e-4de8-8695-ea11b982cb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_b9786308-ebb2-422b-a0d7-bdaf234a3ae6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_PreCommencementTenderOffer_b9786308-ebb2-422b-a0d7-bdaf234a3ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_0b770b6b-902d-463b-8227-ceadbe0b2a0b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_0b770b6b-902d-463b-8227-ceadbe0b2a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6870eb24-4749-4d6c-b796-ce687eb672bd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_Security12bTitle_6870eb24-4749-4d6c-b796-ce687eb672bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_059620a7-b8db-4c62-aefd-5edbbe5418ce" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_TradingSymbol_059620a7-b8db-4c62-aefd-5edbbe5418ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f5266306-0f52-4802-9dcb-0d0d0bbe8e2f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_SecurityExchangeName_f5266306-0f52-4802-9dcb-0d0d0bbe8e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_fefb4c79-cd4c-47e2-97c5-03c42a312291" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afa0a876-96d5-4907-b2f5-81b4e4dafc98" xlink:to="loc_dei_EntityEmergingGrowthCompany_fefb4c79-cd4c-47e2-97c5-03c42a312291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g725933allogenea061.jpg
<TEXT>
begin 644 g725933allogenea061.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  P ,P# 2(  A$! Q$!_\0
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M[Z7_ .AWU0_\%+#_ ,;^OV>?^O;0O_3A?5)^WC,L/_!Q/\"6;[OD:2OXF2^
M_G6U/['_ %[9PXQ_O,1_V%4_RB4_^"H!US_@H7_P5E\"_LTMJEWH_@?P^(;W
M4!:N"TTKVYNKBX*GY3(D 6&(L&\LO(P!W$5]H>*O^"-O[./B;X3R>$5^&>BZ
M7;^08H=3L%,>K6[8P)1='=(S@\_O"RD]5()%?'G_  5N\#^,/V%/^"B'@O\
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MPA^%\]QI%E8QB=EG,.P/$HB#,K7$^6DD7#-'"B[AM3'M/A^5HO\ @YYO]O\
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@]/Q^XYL3_9<:3A@:/LVY75E9*-MG[SN[];*^NU[+_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>allo-20200227_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="allo-20200227.xsd" xlink:type="simple"/>
    <context id="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737287</identifier>
        </entity>
        <period>
            <startDate>2020-02-27</startDate>
            <endDate>2020-02-27</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xMzQvZnJhZzpmMjg5M2E2MzM5ZjY0ZmU5ODY2ZjJhOTgwNmE1NDM0MC90YWJsZToyOWI2NWYxYjQ2ZTg0MGU4YWQ1YWNjY2U1Y2I0OGRkZi90YWJsZXJhbmdlOjI5YjY1ZjFiNDZlODQwZThhZDVhY2NjZTVjYjQ4ZGRmXzEtMS0xLTEtNTk_fe55962b-5737-47b0-8602-acdeba8dfb8e">0001737287</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xMzQvZnJhZzpmMjg5M2E2MzM5ZjY0ZmU5ODY2ZjJhOTgwNmE1NDM0MC90YWJsZToyOWI2NWYxYjQ2ZTg0MGU4YWQ1YWNjY2U1Y2I0OGRkZi90YWJsZXJhbmdlOjI5YjY1ZjFiNDZlODQwZThhZDVhY2NjZTVjYjQ4ZGRmXzItMS0xLTEtNTk_d1aea073-bde0-4713-8d56-e75583408647">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0NzUx_7a8c1e19-4fc2-43e6-aebd-5ead9c7ed79a">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0Nzgz_32a602e6-a9cb-49c1-9c98-b2517cb22084">2020-02-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0Nzk2_b4d17834-6ac9-4da9-b85a-a9420edb393d">Allogene Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6MzM4YTVjMmYyNTJkNDE3OGI0NzAxNWMyZWE3ZjUxZTgvdGFibGVyYW5nZTozMzhhNWMyZjI1MmQ0MTc4YjQ3MDE1YzJlYTdmNTFlOF8wLTAtMS0xLTMy_c779a003-ff60-43c7-b037-01b77ec2a05f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6MzM4YTVjMmYyNTJkNDE3OGI0NzAxNWMyZWE3ZjUxZTgvdGFibGVyYW5nZTozMzhhNWMyZjI1MmQ0MTc4YjQ3MDE1YzJlYTdmNTFlOF8wLTEtMS0xLTM0_6e96a0d3-c270-47ee-a951-29636bf1eb6a">001-38693</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6MzM4YTVjMmYyNTJkNDE3OGI0NzAxNWMyZWE3ZjUxZTgvdGFibGVyYW5nZTozMzhhNWMyZjI1MmQ0MTc4YjQ3MDE1YzJlYTdmNTFlOF8wLTItMS0xLTM2_87454dbf-53d5-41dc-ae46-7ee2fed15e0d">82-3562771</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0OTgw_504b1baf-c7a8-4625-859d-00bee4639122">210 East Grand Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg1MDAz_bf3d226e-f225-4af2-80c3-5cf9cfdb9dc5">South San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg1MDI0_73fd3646-16af-4367-8d7b-cacd377bd038">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg1MDM2_9ffb7a56-e4b6-4677-8407-caa95f919dae">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0ODI3_cd1a1c8e-acb1-4ba6-815d-95e8b8ad32e0">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg0ODMy_fd78e6ad-64b9-4b20-bcb0-eeeb09ffc557">457-2700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6OWQ0NTAxYTY2NjFjNDZlODlhZDI5ZGJlNjdhNDY0MDgvdGFibGVyYW5nZTo5ZDQ1MDFhNjY2MWM0NmU4OWFkMjlkYmU2N2E0NjQwOF8wLTEtMS0xLTcx_b025f698-e50b-4d36-8bf2-a84c1731cf3e">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6OWQ0NTAxYTY2NjFjNDZlODlhZDI5ZGJlNjdhNDY0MDgvdGFibGVyYW5nZTo5ZDQ1MDFhNjY2MWM0NmU4OWFkMjlkYmU2N2E0NjQwOF8xLTEtMS0xLTcx_2adb02d5-2a87-45a7-9a85-178e8da172a3">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6OWQ0NTAxYTY2NjFjNDZlODlhZDI5ZGJlNjdhNDY0MDgvdGFibGVyYW5nZTo5ZDQ1MDFhNjY2MWM0NmU4OWFkMjlkYmU2N2E0NjQwOF8yLTEtMS0xLTcx_c564a973-be5a-4fc0-8ce8-7ff340f14c5e">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6OWQ0NTAxYTY2NjFjNDZlODlhZDI5ZGJlNjdhNDY0MDgvdGFibGVyYW5nZTo5ZDQ1MDFhNjY2MWM0NmU4OWFkMjlkYmU2N2E0NjQwOF8zLTEtMS0xLTcx_091b3656-2e35-4110-a0c7-854777956acd">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6YjY5MjdmN2QzOGUxNDUzYWE2OThhNWU4MjY0MDY5YzMvdGFibGVyYW5nZTpiNjkyN2Y3ZDM4ZTE0NTNhYTY5OGE1ZTgyNjQwNjljM18xLTAtMS0xLTE2OA_f480cb6f-0316-4deb-b739-53ac32f2e12a">Common&#160;Stock,&#160;$0.001&#160;par&#160;value&#160;per&#160;share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6YjY5MjdmN2QzOGUxNDUzYWE2OThhNWU4MjY0MDY5YzMvdGFibGVyYW5nZTpiNjkyN2Y3ZDM4ZTE0NTNhYTY5OGE1ZTgyNjQwNjljM18xLTItMS0xLTE2OA_ed00b22d-03f0-4de1-bf63-4246859a7456">ALLO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGFibGU6YjY5MjdmN2QzOGUxNDUzYWE2OThhNWU4MjY0MDY5YzMvdGFibGVyYW5nZTpiNjkyN2Y3ZDM4ZTE0NTNhYTY5OGE1ZTgyNjQwNjljM18xLTQtMS0xLTE3MA_60d2bb4c-8192-4bfb-9885-0fca7b04605f">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMmE1YWJiNzM5MTQ4ODVhM2ZhODNhYWZiNjQxNjZlL3NlYzo4ZTJhNWFiYjczOTE0ODg1YTNmYTgzYWFmYjY0MTY2ZV8xL2ZyYWc6ZGViOTkzZGM4MjljNDdiM2JjODZlZDM2NWIxNjY2MjkvdGV4dHJlZ2lvbjpkZWI5OTNkYzgyOWM0N2IzYmM4NmVkMzY1YjE2NjYyOV8zMjk4NTM0ODg1MDQ5_7a5483ac-200d-464b-a732-0034602276de">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>11
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "allo-20200227.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "allo-20200227_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "allo-20200227_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "allo-20200227.htm"
     ]
    },
    "labelLink": {
     "local": [
      "allo-20200227_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "allo-20200227_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "allo-20200227.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "allo",
   "nsuri": "http://allogene.com/20200227",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "allo-20200227.htm",
      "contextRef": "i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information Document",
     "role": "http://allogene.com/role/DocumentandEntityInformationDocument",
     "shortName": "Document and Entity Information Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "allo-20200227.htm",
      "contextRef": "i29a54bb04e4d486f880c6a25a6f6d429_D20200227-20200227",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page.",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://allogene.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M/_QNPM9I<S#_V/@JV+7PZRZZ+U!+ P04    " #0.UM0F5R<(Q &  "<)P
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M1&KX^!US'I,MM=_FY!;[3]&_LYO7=O5>ID5R=V5&Q'Y T!F"3(C$UIX$*"I
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M+TWRL&6=-XJ<[O9GJ,6@WLX%][]$\0-02P,$%     @ T#M;4!9M(W]# 0
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( - [6U"-#H12[@   "L"   1
M          "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( - [
M6U"97)PC$ 8  )PG   3              "  ;8"  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ T#M;4-'S4&B? @  F L  !@
M ( !]P@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( - [
M6U"*<@G4< (  #8&   4              "  <P+  !X;"]S:&%R9613=')I
M;F=S+GAM;%!+ 0(4 Q0    ( - [6U"ZH3F*UP$  #(&   -
M  "  6X.  !X;"]S='EL97,N>&UL4$L! A0#%     @ T#M;4!9M(W]# 0
M/ (   \              ( !<!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( - [6U#_P"8(O0   (4"   :              "  > 1  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( - [6U +C]@#(0$  %<$
M   3              "  =42  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   *  H @ (  "<4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6605572272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>Feb. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover page.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 27,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Allogene Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001737287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-3562771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">210 East Grand Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">457-2700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common&#160;Stock,&#160;$0.001&#160;par&#160;value&#160;per&#160;share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ALLO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001737287-20-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001737287-20-000010-xbrl.zip
M4$L#!!0    ( - [6U"92D'[214  $>H   1    86QL;RTR,#(P,#(R-RYH
M=&WM/6M7XLBVW^=7U&7NG6.O94%2>6.W9WD$'7H$6L5VX(NKDJI ,"1,$A3X
M]7=7$A1\-7JT&Y1>J[N!>N[WKEV[JC[_>SSPT16/8B\,OA3DHE1 _][]_#\8
M__V?DR-4"9W1@ <)VH\X33A#UU[20^>,QY?(C<(!.@^C2^^*8IRVV0^'D\CK
M]A)$)"+=*8S*NL(TC1**J4H,K"J&CBF3->Q:BD%U)LN23K:[9:YPQU$LBF67
M,:RZEHUMV56Q04W7)@;77$G99F63$ZI1VS842U9-4Z.*2TV%4M?655G7N1BV
MEP!T &$0E\>Q]Z702Y)AN52ZOKXN7BO%,.J6B"3)I;_K1Z=.CP\H]H(XH8'#
M"WDK;YS@F#L++>%[L1M>E;S ]P(N\%1*(AK$;A@-: )XA$X!*LG$BGS;ST(7
M8SOR\^%E9:ZC677X?OE8 TDIB6*;QC>S%*7>$_7O0L7X;>VTY@PD*!!3LK D
M+TP^>;CS'V& 8*+?S/$>3#D%9,NR2FEI7O7Q2H*<!: JIVSW\X G%(F:F/\S
M\JZ^%/;#( %>Q:W)$"!ULF]?"@D?)Z6T96GWM]]^^YQXB<]WJ>^'6'"I1(CQ
MN93]^+F4=6V';++[F7E7*$XF/O]28%X\].FD'(0!APEXX[*HR*/LH\<8#]*/
M4-X @8D\)QM_G)QP]TO!(Q;55-N65*XRU=1=TY0<G1*-ZJ[.5&)=5&93N9E3
M 05T((;F7KD:P/PF^P!.1/U:P/CX+SXI((]!UTSY/K$KX=41.;EJ*_41ZU>O
M.H=6O]GO^?5!56Z??_4:T[I6;QVKS<KW7IUT>LU*H]<^[WB-_O&XT>_X1TK#
M;T]#M=/ZVFN<'WCMOC-MMJI2L]*5VZW&H-WJ3MOG!X-VORW56VW2^6Z.Z]/C
MJT[PM=>9#@?U?E>KDRJIPS@=J-,9G&G-"M3K?^TU6]WK!LRC4:E+]7U+@OG$
MG58X:9[72..\/6[WCTFGU97JAV=J^_P8YMOHM\F9W"8UJ7EX<MGQ\C9_?^W9
M ^8W^S4-YB%W^@=>H]+QFY7CZTZKU^L ;&T"T+2^]Z%/M7-X,OA[6DWJI]+X
MJ%5-&JW+"Y=KFJ43&VN& @K(L"5LZL"EU&'<IB9S;1/(*X%*@')B E\LT/0M
M2;P':I8)57O@T^Z&M$N0MK9 6B933B5#P3;C$I!65K#)-!US0]-,195,734*
MNR[U8WZ/JJ5%(8ZXRR,.ZC+>_2S44CE.;0.0&:5JJIR @OE2B+W!T!<J-?VM
M%PDN6- JQ7',0%F4%OO(AIL?(_T:AZ,H_9;J\G+.6AD?O(2U9AWQ5'7,OGE,
M?'<]'J%T0OQ!P[9?^VM1"NXVWIW]M-C[$- 9LMDW,#E14@&O85=,*C4&-UW=
MEMU,DSU2=58R^SX;I+2 J!E6;]!8FM/1)=#DF3I/T?DCQ^%"+LRWR4U CPO'
MIJPH14,;)CO7'DMZ95F2_F^GD-;;_1P/*3"0'96@=?8YZ^1>5P,:=;T )^&P
MK$)7A<>;/MXH_VJ'21(.RGK634)MG]]IX',W*=-1$LZ:I Y:]HL=1H @[(2^
M3X<Q+\\^[ B48NI[W: LVF??O4 P0%F"L6;V,', <#INCA++*IJ:DF(E =PG
M;#:?'&/%#&.EA-TOM,RB)#U1OM"XE':?#0$3%VC[4E *=^D%L[6I<]F-PE'
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M53^4.E-ZD2TKIH-4O3FS1V.ET_&/(BWMP(M\.KW+TD7FGHUY%#&L;!5*$*0
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MWDN2=:'VD&+%W& 2K MB77JUWW>07/Y3%^_$K"RX+,>0*Z-0HD"$8@0P21+
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M?UX+(W&5EA,]QC&%3,<QB#6T^F=0 <'M$244<\H0(JAUE[MI_-1$/P<5Y":
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M]-CUH??NKC?,#MQ7UP>UW5$WC&N2\#KOE_;H[8O5)^EB[_.W+_X/4$L#!!0
M   ( - [6U!3#,V\N08  +LQ   5    86QL;RTR,#(P,#(R-U]P<F4N>&UL
MU9IM3]Q($L??YU/,S;Z]9OK![@<46'%L<D+';E#"*JM[,^J'ZL&*QT9M$^#;
M7[5A=D,@=Q98PB>DP6/W=%7]^^?J[K+?_GRSK1=?(755VQPLV1Y=+J#Q;:B:
MS<'R]_/W1"]_/GSSYNW?"/GC'Q]/%[^T_FH+3;\X3F!["(OKJK]8? [0?5G$
MU&X7G]OTI?IJ"3D<?G3<7MZF:G/1+SCE]/NK:5^*4):66V(+KD@AE"0VL))$
M(Y25@3$J^=\W^R# >V$L83$$4D3CB&.Q(,KJZ+B",E(Q=%I7S9?]_.%L!PL,
MKNF&KP?+B[Z_W%^MKJ^O]VY<JO?:M%EQ2L5JUWIYW_SF4?MK,;1FQIC5</7/
MIEWU5$/LEJW^^/7TD[^ K255T_6V\=E 5^UWP\G3UMM^T/Q_^K7X88O\C>R:
MD7R*,$X$V[OIPO+PS6)Q)T=J:_@(<9'___[QY$^3MJ[;#32PY]OM*E]<[4;7
M-N%=TU?][4D3V[0=/-U=PRB&7OO;2SA8=M7VLH;=N8L$\6"9^R5YN"GG*OOR
MTZA^5W]Y?)F@R\WS]5,\<=]]]G%2[^&FAR; G5@[XW7K'S2J\U"U:??+VCJH
MA[/K -7ZN,6[Y\AU?;*^7]MHJ=4(L9&A)(6ABC@>2Z*9*Z (-GJC'XJ5H^DP
MG&%D._![F_;K"CO&$68F'Y!\0"B[']>?'AF]$^YYWN]D.<>V:U\R([15Q!<^
MHO/Y)BL%)R&"X!14Y*69P/EO;3[T_=MA/TI^T:8 ";/2SJA-_@$"C^^(^Q:K
M2YNP(^(OJCKL?IW3TQ3CUK<3Z'<W..CN<H%11T@)PNG=V/PPN"&R'G,U#"VG
M&/<S2%6+=TOX!9/YVDOKK0JH@F(. ^"46$5+(J'0TFKM,)P) 7A@?!0)?/XD
M/%_15T;B+F5^A$V5E6CZW^PV^Q]C+'%Z-F6!\VXA"F)9X9!P4,KY"-:6$Q#Q
ME.U10(CY O%B/6?!PS%JE6Q]@K/DS;_@=JV"TP67$I=J.0#-!7'&"F(-TXZ7
M'*QGDP'QG?%11!1S)^(EBKXR$D>8X$).<N]KNUD76DL,&=,:B)"G.X_371"$
MEU(82HWUL9@ A0=&1R%0SA>!YRLXBVQP@EO#=-FF0?%/*#P<MU>(\^UQ&V!-
M<>,6N06B(_);: '$F(B+($,E>!55R?EDN>&_NC(*$SE?3*96>Q;PO*]J^.UJ
MZR"MC8C>,NZ(,)*2 C,<T<)%HA455)3&\P"3D?*7W5%8J+EC\4P=9\' N;TY
M":A5%:N[^L=](*52X(07A"F.F5#8/ D:1H!*8X'[,OCI4L</G!A%AYX['5,H
M/ M4CD+ (>CN_YU6#; UPR$US%/B;(DYSTA$7=""!,I8T-2$&.EDF#SAP"A$
MS-P1>:FR<\+C& \_I//VNEDK+UB(A25<,A2E=!Q%X9(X(;C54C$KI\LAC\R/
MJV31_Q,VGBGKG,@8%DP?TEEJOU:-A[66UH7(4(W /"EX:5 AS@F+FFI-G?%R
MNE+&TSZ,8V3&Y<[)!)X3*&=MU]OZW]7EL*QVD1?@:,"=F"\P"@S%EB4.,6=&
M $A?QC U)@\\& ?)C"NA$XG[RHCD#'B4P Y^B\"Y\(4CX!U*H:D@6K- )--.
M!2FHXG("*+ZU.0Z#&=<_GRW@*P]\?C);GUVTS6Z3Q501+0=+E \Q/Z)FQ/+(
M2%3*<Q:I"^44$\?W=L<!,.-RYXN$?&4(/J>J[Z$Y;K?;J^9^(]6MJ9!E8(X1
M:?-V.Y?PC1:!A+*(#IP,8*>8&YXT/@Z'&9<^7R[I*S/QJ:TK7_55L_D5%SZI
MLO4:G"MX-+C:H1)($4 3+4U)P#+FC.;>L3@!$(\MCZ-AQA7.%XKYRBB<)<@<
M RY[AZ?_^262]"&B'VMGE,;Y3!,,A^,2ASMB:<B+8ANY**RP,,52X<<>C$-C
MQE7.B<2=%R(G77<%Z=M8J%.*.NF(H;D@)X4CFG-%/&8\!]1Q2]WTH#SR8QPN
M,RY[3BKT:T\QX*]PFKQEW)U7?0UKJ14%QW&OI J#.5%ZXI21Z#M>P>E1<3?%
MBN-[N^.@F'&A\T5"OC($Y\GFUV\_W6Y=6Z]I:22G%N/6P9'"2TXLQ$!*",Y!
M63#MIWA4]L#HN'>Q9ES+?+Z$,TD [V[\A6TV,+PT%$LN<=:3A.)1WCQS8H)W
MA ;\PP@T\$E6F4_8'D?"C"N6+Q9T%I7*=UM(&P3ZGZF][B]PNKNTS>TZ0G2%
M5X;X4."J60&&H7Q)J/ %MX)Q;J9[%^M)%\;A,?M:Y<OEG8R2MZM'4I[BB<,W
M]Q?R1W[;__#-?P!02P,$%     @ T#M;4'*D\(W%&P  )UP! !H   !A;&QO
M+3(P,C P,C(W>&5X>#DY,7$T+FAT;>U=6W/;.+)^/[\"Z^1D["J*)G67G4F5
M1E8F/F4[F5BS4_NT!9&0A#5%:GBQH_WUI[M!2I0LR9=8,:5@=M9C4P30:'S=
MZ!N@]_\X^]SI_>M+EXWBL<>^_/G;Q7F''92.C_^J=(Z/SWIG[%/O\H)53<MF
MO9#[D8QEX'/O^+A[=< .1G$\.3D^OKN[,^\J9A .CWM?C[&KZK$7!)$PW=@]
M^/ >G\!/P=T/__/^'Z42.PN<9"S\F#FAX+%P61))?\C^<D5TPTJE]*U.,)F&
M<CB*6=DJ6^RO(+R1MUQ]'LO8$Q^R?MX?J[_?'],@[_N!._WPWI6W3+J_'DC.
M&XYHBJ95=ZQJO]KO5[E5MP=EMU*N-YK]ZK]M(/(87E=MHGCJB5\/1@+'/JF6
MS49M$I_>23<>G=B6];^G!_3>A_>#P(]AL! :JU]5'_=ZBL6WN,0].?1/:#ZG
M8QX.I5_J!W$<C*%/Z/Y =9<UZ7/G9A@&B>^6G, +PI-PV#\LUVI&]G]FF=;1
MJ?KLC47_G&('I0$?2V]Z\DM/CD7$KL0=^QJ,N?^+$<'RE2(1RH%Z,9+_%6IL
M^O-.3;<!_7C2%Z5T^G:9)MS]-I)]&;-6R[079YN;9SJM.)C,YB3'0\:]^->#
M8:-<:U4JW/."H? %+H#YG\GP@$6AL^G3Q;6P)]^RA6C4X?=5ZS;AK@MH*A&K
M3UI 1X[_#J!%A!FW5RS>\SKZX<M6?]RRM5.&LMY(A'PBDE@Z$?LJ)D$81^QC
MD(3QB/V1\!#FPKCOLH^)Y[%_"1Z"S-DM]E'ZW'<D]Z!-E'C0YB6XM9GMU$SZ
M+C0Y*=E-Z"CKVA,#P$"M0-)276:[74.VOWO3+)?KI]D4BTOJ F?MJJEX>^Z#
MFL^M^2 ,QBP>"?9EQ"/!;-:^N/A<JEGXRY=/;=@9\&WI0P./3R+AOGM3;9Q^
M%8.0.W$03ME5X)<^!>[P!MZYF(XG(R"<X+;08<.NL3^OSO_9_7K=OGBXTTN@
M34X\P2ZGPL,./_LEV*.<&S8(0O9'6>T:.,H?5?K=P E-A!/+6^%-UR-9 _"U
M 9CAJVT0[*Y@0=COH,9"CN8'K&DL2YTST$^HWSKMKZS'SD'!P)*YM/@*5F5V
M)F"E@PF:"+CXCH"5=]GYU1GK>*#C0+6).;C_-*]-]O&L;8+A,9YP?\JZWQ M
M$8L#ID0B%C V:_?[H;B59+AD )ZA-<6=!E<!2%T-+EC=/FQKA"2U;,%@KH!0
M7UQ/0FB&]F:TL''BQ.W&*?N=CT'=7 NP7F-<_G.?C*,@--B5#(,A=T04<X"<
M A# !! $PP(. 7  $H0;- ]@K$_<&R !&C0%(77-E@@ZXSKICV44(6Y0R9!6
MZD![Z0"&.@ <Z8).,!26*G;=0&61ZJJ&-==5&0^B9/*C65"GZ3S(@UL1QCBK
MU'H#@QY8T+M\?PPD%WGM#CX8.\I<M@.\[8%[)^)TBR4?H0L*C*PLK;D*0.IJ
MS=4EJXB\N3L)WM[;6K/%+J7GH1Z#O:C#HY%!/UGW[T3><@_6*J)]\-R_A8T,
MK:=(+W !2%UGS_@#$9)IT>'@O>/*_27Z#H]B=NV,A)MXJ<S6WKVI-4\KL!5=
MLB\]\J>:N4?=WO:<^R*S]>##]><_>Y_8=?N*??S:ONJ<7W<^HTAX<F :[*/H
MAPD'A[/<,)2V(SO0/F4KHRL&B(UCLL,K'KG\;V(O601'8 XP)S472F ?#@7K
MRR 6SLB'>0ZGS$G=C@E(IA!H@I*AZ,Z=&#04LQB9=)CR? YGA@7056V63X^P
M&= C@4.X[ [Z.6";QH'+H?<PN)6H$H":()P$(7HUR<15SHW+0@H.$6(H.O1W
M+CHT2#RO-)U%AP:SZ%"810I@.*1Y N0';L242W8&GM>X#WU4;(-:FO<WC-T%
MS[LWE>JITJ\<]":#_7W*HL0!)R "AC'B%S(F@XL)XLFX@\OMR6B$2^&1$P(,
MSZW),. >H.EN))T1*&K'2UR@&KF+WD4?FV:8N M"#[CA\2B"U9[POO3 786W
MN1,&\&R<A4I\F/,@\1UT?I2.Q_ZD<FYQ0TBI&,@0M$>&5A:CFQ3A;C&!UVA_
MH+TD3$,S#&87SB,S?#@$0$3@;#,_%_GQ\I&?&4EC%;TQB(TLXA+PP@&AK#/B
M_M!@E^89".&7D?H/]"M=<N<[(RD&X&$))\& #OL\&$@GQ6DG*'U$@,"?Z-O-
M^$YC?(;YC0-D73)6J Z<!)W\.QX"9,?\!B5O'EF8"U/*+QDRT RB% &9\.8$
M9-BG>!D')H#2B*>TW#E6P?*"LQ=+/X&%CTF,6#01P#A@"ZH4$U2(C!14Z/4^
M11KD&&61XR*#E@%TW0GF!<$-^I.N&,,:Q@05D.E@4()_811'3&(&TLS3R,9=
MP&X$B?TPY&,UB8G'E0\SIWTB;X,8_AO%B0MS-8E5NRBE]R+A2DHQ^@/4?8)G
M'CZ_;]'L[MQFX=C#%9&QH^>:;I6Z-MVV'FBG[="86Q*I*A9*,<\6=AXGQWA[
MG 4;5VMC,NQRZGBE#CZ\^G1QE*H=E/DI S7JP80B-6J]VIB3]4N4Q3%J9="=
M?N!XF 6FAYAK98?C=O^(T?8W 7,!M2[2KT9S!>AYVEU",02>^B;+,@RDIX "
M5$B^BI/U49V)"&U*%Y4E9V/ATBXT%M +*-QYE-74V"X J:NQW9N%U(/ I5WG
M+$Q@7W7'@'':MQ 1#L;A4[0K=U,.N:HQ(.I4FPD82HYJ<'A^=7:DS*G%)$$:
MM$]CM!&8.M]B-MR<-'!H!TV<&(WL &R.%+>AC)-O<LS[\&!0BD"ZG)&9'W""
M"8 @B;PIVCTB#!5V>31[R013%^W!K,(!/A6>'&/@62R-$0HG&/I46<%<6 WI
MDZF5]620R7^'R,=I)Q&%D#GKAP%'"R=5 K"73Q*/YFJDYJ+R( )H ,)^3UG0
M?CBG0GR;!%$2BA6VN1:J(@E5EIT2\^R4S&6G^(KL%%J1J76?WU:RG>20MI7R
M49::B%1J(O/\TE9HG.*&(=0N5$X;D[GJ@8\:HD>++X);B*1'\^'FFQ80BUXC
M;C1+I#@"^G$1K)E;DNU#K,_1QUBSF9!0\!66;)8$I(&?Y7'NK"V(B2QE"_[6
MN6QK6[!8I#XLVJ/<Q@%.9=!/P!N?KZ?R^C!B1)$W?(DF-\]B9G&8&#O)H@3+
M+C<[O+P\TB94$4C]#O< ESO3\_/JF2>Z")>7!IA D1SZF2$3B4@%FR(^$/%4
M*>7  RU/P:5I/FEN,N5'I(."%^!%N"FE%1FX02&*Y&!*/0:3&"R.5-EGW:">
MQS$6 EUSI8[FTRWW$MSDUFP$V 3\!3< AR?.^F$#^,F1:%]M+,X4?!=H'DU&
ML(XNF#MSIF4Q&MI3N>.$"05=,N>$."CSG@N*I",GM"#HE52U5U(84M>*U/]Q
M7X7SJ21L)EJ9*@78!KE(/8#"\W@_2+T(PL"Z^I %E,Z$$X#AY$I.EGO(BDKD
MDO<SI"*3:%9D(N=%)OY"D<D3A%R9;YL,R!CE.$_N3)'D#,-1KF9%@[T(I#YL
M4OB!\CU3(Z%NU5"U2<S94*R_EX1]-!)WM'YB)XI3,!.GBH14%#Z-E.$B>%A;
M$8*(SHP[):O9LK!<GC#-X*6YH,& A!CZ<:9Q<(/['*B1<1H*0.'.Q3O QTJ5
M!+;%#!,V%/X(\WC^<$-U=Z".?IR@<L%\2_X\Q-))B8/5+7D_"KPD%J?IL0?K
MR4<JU,]1.,]*#T4)O%U^4^(#T-XGW+OCTVAQ_)<[QK%SZDOEJLB(<J8&ZGL\
MP4.Q,!=3M)&,\"-ASG4"&F_N;8H&W%E",=L)\XEHPE#>Z\8".97,LN]O"4\M
M^R]2T<@Z/QNPD.[47^1$X!OL3\JB/[M69A<@M;\[XH:"32/;*BFF/+<,9]I\
M,96:EQ.,U#J@])3/+5WFB>1&C"4W6*]$(:\Q;6,H<2K#3%8;Y=,16_2*PT.0
M1V")F:]!3:-K*'BS<#A, D589'7'_:G**8NT4.]IHEF0]5TC@4NGE^X=5=)B
M6 !2UYSO('OE7EE0SAL;<1<K%9MFBXWGM8H.U2KB3R;FM8I&&CB8%2OJ%$8A
M2%V]]B"=H)&<$2U:7E6BTO(C@44NH6!OJRVS.EO[+)ZY5)-&/BCB9JE(ZFT]
MUQ9>P@PXH2:* ^>FI/()6'\% RHS.1V<B'IK Y?RL)M1QJ,H<%3\;69$8] ,
MC:59_=:]<,%5$ -Q^4 !)D73"6$I$*GHV5S"1S+(K@)+,S)-]A!?9SRDT>:L
MLEO/Y)7V_(M ZFHA4X?E5"TPSV7<;\4]%-7,\K/%K#$'X-.@LPG_PT?37LN-
M?Y^X<MVL:V#O&;"O1,P\+&G=#%4JO7A;M^=ZW, :U;>666NBY\NB$0]%OD[B
M\5L$#/'6KLP-DXU@QBW!SV@FHNQF=8Y+195M-BLO056U;MHSJO;(TJ>B^[E]
M_WL"7I?O""VF!2!UC8$_RZJD.8:Y:/S>;G^9B81*M?4%_!O?">&CUIZ;7F2,
ME9MY6RP3#$R5C,D0>YJ(-.:=P<!O&[6%P<2WK'\,$,CQA#NQ*J.>>_=]O*L&
MDZ-Y&XOCI0)4<K^;1QO67!^RZ6C1F8BY]-:54;_ZC-;(U0R85+8T"K"N@GEH
M6SCSN3K97._2N:J3,SR>GZ#BYMAD7[@C!])A2"*CN UK+KS0A<8B]-4+6+,O
M(R?!S>O>P1F*R*JX/I;V91A3YW),UJ-\=):27Z87R>U/62P\,1D%/NP@$T]@
MSM#%(6QVV*S7CUBK:I5J5KW,#K$L\PAW'OBH:K6.6-FNEZRZW62'>(U"Z*<Y
MR".5@\B-='[&_(1\]FS_5;0@!7)^.<SS$5"NX_^VB8!RJVE;M5;Q->O!!\7^
M#(39N9 Q1XS<@O#QO@=:S<^7O_Z"MG$_DC$=-'F920X&VYPD7AZ6G6DS06_O
MPL(P=;9H7K0<A""9O)_ER6$<)=+=6TK+1X).7*&EF)7RSF2'PX839(MLT!FB
MB0?:9G8,Z.&5I@K(":B/;[0G>E,&"@@TUGYM1NU^D,2KSUP6=28/;4*+YT8I
M6(07V*7.#%6!7\.D1^R:^^PCWE<#&TA@4);NA<^2.B.88@B_8/X#GE&!^ 2
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MZ:=?0GF+J<MKX22A.BQ\(;/R,_95(!I9VR$U8;=:-66++%(VYE,J/XN",=J
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MK5OY+@XV4[+PLQ^X4_C/*!Y['_X?4$L! A0#%     @ T#M;4)E*0?M)%0
M1Z@  !$              ( !     &%L;&\M,C R,# R,C<N:'1M4$L! A0#
M%     @ T#M;4%03V\ZU @  60H  !$              ( !>!4  &%L;&\M
M,C R,# R,C<N>'-D4$L! A0#%     @ T#M;4/:J7Y*. 0  &P,  !4
M         ( !7!@  &%L;&\M,C R,# R,C=?8V%L+GAM;%!+ 0(4 Q0    (
M - [6U"3>YS**@(  -\&   5              "  1T:  !A;&QO+3(P,C P
M,C(W7V1E9BYX;6Q02P$"% ,4    " #0.UM08T)6EX *  #)7@  %0
M        @ %Z'   86QL;RTR,#(P,#(R-U]L86(N>&UL4$L! A0#%     @
MT#M;4%,,S;RY!@  NS$  !4              ( !+2<  &%L;&\M,C R,# R
M,C=?<')E+GAM;%!+ 0(4 Q0    ( - [6U!RI/"-Q1L  "=< 0 :
M      "  1DN  !A;&QO+3(P,C P,C(W>&5X>#DY,7$T+FAT;5!+!08
..!P ' -(!   62@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="allo-20200227.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://allogene.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="allo-20200227.htm">allo-20200227.htm</File>
    <File>allo-20200227.xsd</File>
    <File>allo-20200227_cal.xml</File>
    <File>allo-20200227_def.xml</File>
    <File>allo-20200227_lab.xml</File>
    <File>allo-20200227_pre.xml</File>
    <File>allo-20200227xexx991q4.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
